HUE046050T2 - Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére - Google Patents

Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére

Info

Publication number
HUE046050T2
HUE046050T2 HUE17171155A HUE17171155A HUE046050T2 HU E046050 T2 HUE046050 T2 HU E046050T2 HU E17171155 A HUE17171155 A HU E17171155A HU E17171155 A HUE17171155 A HU E17171155A HU E046050 T2 HUE046050 T2 HU E046050T2
Authority
HU
Hungary
Prior art keywords
nocturia
initial period
increasing initial
orodispersible
desmopressin
Prior art date
Application number
HUE17171155A
Other languages
English (en)
Inventor
Bjarke Klein
Jens Norgaard
Brad Shumel
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE046050(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HUE046050T2 publication Critical patent/HUE046050T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
HUE17171155A 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére HUE046050T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21

Publications (1)

Publication Number Publication Date
HUE046050T2 true HUE046050T2 (hu) 2020-01-28

Family

ID=41100519

Family Applications (5)

Application Number Title Priority Date Filing Date
HUE17171152A HUE041370T2 (hu) 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
HUE17171155A HUE046050T2 (hu) 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
HUE13181216A HUE030409T2 (hu) 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin-készítmény az alvás noktúria által meg nem zavart kezdeti szakasza hosszának megnövelésére
HUE16165875A HUE039013T4 (hu) 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
HUS1900024C HUS1900024I1 (hu) 2008-05-21 2019-04-26 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE17171152A HUE041370T2 (hu) 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére

Family Applications After (3)

Application Number Title Priority Date Filing Date
HUE13181216A HUE030409T2 (hu) 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin-készítmény az alvás noktúria által meg nem zavart kezdeti szakasza hosszának megnövelésére
HUE16165875A HUE039013T4 (hu) 2008-05-21 2009-05-21 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
HUS1900024C HUS1900024I1 (hu) 2008-05-21 2019-04-26 Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére

Country Status (16)

Country Link
US (2) US9974826B2 (hu)
EP (5) EP2296686B2 (hu)
JP (5) JP5767103B2 (hu)
CA (1) CA2724653A1 (hu)
DK (5) DK2712622T3 (hu)
ES (5) ES2756706T3 (hu)
HR (4) HRP20161066T1 (hu)
HU (5) HUE041370T2 (hu)
LT (5) LT3225250T (hu)
LU (1) LUC00015I2 (hu)
NO (3) NO3085381T3 (hu)
PL (5) PL2296686T5 (hu)
PT (5) PT3085381T (hu)
SI (4) SI3225249T1 (hu)
TR (2) TR201807224T4 (hu)
WO (1) WO2009143356A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
HUE041370T2 (hu) * 2008-05-21 2019-05-28 Ferring Bv Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
EP3868370A4 (en) * 2018-10-17 2022-06-29 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for nocturia
US20230149330A1 (en) * 2020-04-14 2023-05-18 Nippon Chemiphar Co., Ltd. Sleep quality improver
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
EP0084705B1 (en) 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
TW279133B (hu) 1990-12-13 1996-06-21 Elan Med Tech
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9101022D0 (sv) 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
CA2070061C (en) 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
AU669856B2 (en) 1991-08-26 1996-06-27 Abbott Laboratories Compositions and methods for the sublingual or buccal administration of therapeutic agents
AU666509B2 (en) 1991-12-24 1996-02-15 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
WO1995001368A1 (en) 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
KR100193104B1 (ko) 1993-06-29 1999-06-15 훼링비.브이 비강 투여를 위한 데스모프레신 조성물
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5707648A (en) 1993-11-17 1998-01-13 Lds Technologies, Inc. Transparent liquid for encapsulated drug delivery
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
JP2551742B2 (ja) 1994-05-23 1996-11-06 三星電機株式会社 医薬品投与用皮膚傷形成装置
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
ZA975326B (en) 1996-06-18 1998-01-14 Alza Corp Device and method for enhancing transdermal flux of agents being delivered or sampled.
US5763398A (en) 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6511974B1 (en) 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5932745A (en) 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6090803A (en) 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6344451B1 (en) 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
JP4435424B2 (ja) 1999-02-15 2010-03-17 大日本住友製薬株式会社 口腔内で速やかに崩壊する錠剤
IL144948A0 (en) 1999-02-18 2002-06-30 Biovalve Technologies Inc Electroactive pore
AR014640A1 (es) 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
ATE501751T1 (de) 2000-01-07 2011-04-15 Valeritas Inc Injektionsvorrichtung
US20070032410A1 (en) 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
TWI287984B (en) 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
PL365677A1 (en) 2000-10-26 2005-01-10 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
EP1339442A4 (en) 2000-11-30 2006-12-27 Biovalve Technologies Inc INJECTION SYSTEMS
CA2430590C (en) 2000-11-30 2012-08-14 Biovalve Technologies, Inc. Fluid delivery and measurement systems and methods
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
KR100904158B1 (ko) 2001-03-16 2009-06-23 알자 코포레이션 펜타닐 투여용 경피성 패치
ES2282423T3 (es) 2001-04-12 2007-10-16 Wyeth Azepinas y diazepinas bi- y triciclicas n-bifenilcarbonil- y n-fenilpiridilcarbonil sustituidas como agonistas de la vasopresina.
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
EP1381608B1 (en) 2001-04-12 2007-10-10 Wyeth Cyclohexylphenyl vasopressin agonists
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
UA77000C2 (en) 2001-09-13 2006-10-16 Kissei Pharmaceutical Crystalline form of hydroxynorephedrine derivative
US6723077B2 (en) 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
MXPA04004501A (es) 2001-11-16 2004-08-11 Yamanouchi Pharma Co Ltd Derivados de 4-4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o sales de los mismos.
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
NZ535861A (en) 2002-05-07 2006-11-30 Ferring Bv Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
GB2421689B (en) 2002-08-05 2007-03-07 Caretek Medical Ltd Drug delivery system
WO2004030743A2 (en) 2002-09-30 2004-04-15 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
NZ539199A (en) 2002-10-09 2008-09-26 Toray Industries Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
NZ542815A (en) 2003-04-28 2009-01-31 Astellas Pharma Inc 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or salt thereof
US20060193825A1 (en) 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
US20040265365A1 (en) 2003-06-30 2004-12-30 Daddona Peter E. Method for coating skin piercing microprojections
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
DK1500390T3 (da) 2003-07-25 2005-09-19 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
US6930932B2 (en) 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
AU2004285481A1 (en) 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
WO2005042054A2 (en) 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
US7097631B2 (en) 2003-10-31 2006-08-29 Alza Corporation Self-actuating applicator for microprojection array
CA2545194C (en) * 2003-11-10 2014-10-21 Seymour H. Fein Pharmaceutical compositions including low dosages of desmopressin
DK1530967T3 (da) 2003-11-13 2006-07-03 Ferring Bv Blisterpakning og dertil hörende fast dosisform
ES2254858T3 (es) 2003-12-29 2006-06-16 Ferring B.V. Metodo para preparar una forma farmaceutica solida de desmopresina.
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
WO2005069758A2 (en) 2004-01-09 2005-08-04 Alza Corporation Frequency assisted transdermal agent delivery method and system
HUE028833T2 (hu) 2004-09-09 2017-01-30 Yeda Res & Dev Polipeptid keverékek, az azokat tartalmazó készítmények, eljárás elõállításukra, és alkalmazásaik
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
CA2604916A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
EP1871759A1 (en) 2005-04-22 2008-01-02 Wyeth a Corporation of the State of Delaware Benzodioxane and benzodioxolane derivatives and uses thereof
WO2006116151A1 (en) 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
JP2008538577A (ja) 2005-04-22 2008-10-30 ワイス ジヒドロベンゾフラン誘導体およびその使用
MX2007013163A (es) 2005-04-22 2008-01-21 Wyeth Corp Derivados de cromano y cromeno y usos de los mismos.
CN101203217A (zh) 2005-04-24 2008-06-18 惠氏公司 调节膀胱功能的方法
WO2006138719A2 (en) 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US20080195035A1 (en) 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CA2584456C (en) 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
WO2007127976A2 (en) 2006-05-01 2007-11-08 Georgia Tech Research Corporation Particle based molding
BRPI0814986A2 (pt) 2007-08-06 2015-02-03 Serenity Pharmaceuticals Corp Métodos e dispositivos para a distribuição de fármaco desmopresina.
HUE041370T2 (hu) * 2008-05-21 2019-05-28 Ferring Bv Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére

Also Published As

Publication number Publication date
EP2296686A1 (en) 2011-03-23
HRP20191854T1 (hr) 2019-12-27
EP3085381B1 (en) 2018-04-18
JP5767103B2 (ja) 2015-08-19
EP2296686B2 (en) 2017-11-01
EP3085381A1 (en) 2016-10-26
JP6506821B2 (ja) 2019-04-24
US9974826B2 (en) 2018-05-22
EP3225249A1 (en) 2017-10-04
DK3225250T3 (da) 2019-11-04
US20090291880A1 (en) 2009-11-26
DK2296686T3 (da) 2014-05-12
HUS1900024I1 (hu) 2019-05-28
PL3225250T3 (pl) 2020-02-28
EP3225250A1 (en) 2017-10-04
LT3085381T (lt) 2018-06-11
LUC00015I1 (hu) 2017-04-19
HRP20190114T1 (hr) 2019-03-08
HUE030409T2 (hu) 2017-05-29
ES2462465T5 (es) 2018-02-28
EP3225250B1 (en) 2019-08-21
DK2712622T3 (en) 2016-09-12
JP6001121B2 (ja) 2016-10-05
NO3085381T3 (hu) 2018-09-15
EP2296686B1 (en) 2014-02-12
HUE041370T2 (hu) 2019-05-28
SI2712622T1 (sl) 2016-10-28
PL2712622T3 (pl) 2017-01-31
ES2677548T3 (es) 2018-08-03
WO2009143356A1 (en) 2009-11-26
HRP20161066T1 (hr) 2016-10-21
EP2712622B1 (en) 2016-07-13
LT2712622T (lt) 2016-09-26
ES2710454T3 (es) 2019-04-25
PT2712622T (pt) 2016-10-13
PL2296686T5 (pl) 2018-06-29
LTC2712622I2 (lt) 2020-02-10
PT3225249T (pt) 2019-01-17
JP6836618B2 (ja) 2021-03-03
LT3225250T (lt) 2019-11-11
PT2296686E (pt) 2014-05-23
DK2296686T4 (en) 2018-01-02
JP2018035198A (ja) 2018-03-08
ES2756706T3 (es) 2020-04-27
PL2296686T3 (pl) 2014-07-31
JP2016196514A (ja) 2016-11-24
CA2724653A1 (en) 2009-11-26
LTPA2017001I1 (lt) 2017-02-10
EP3225249B1 (en) 2018-11-07
DK3225249T3 (en) 2019-02-25
TR201819189T4 (tr) 2019-01-21
JP6258424B2 (ja) 2018-01-10
ES2462465T3 (es) 2014-05-22
PT3085381T (pt) 2018-05-18
JP2015120761A (ja) 2015-07-02
PL3085381T3 (pl) 2018-09-28
LUC00015I2 (hu) 2017-06-19
HUE039013T2 (hu) 2018-12-28
EP2712622A1 (en) 2014-04-02
SI3225250T1 (sl) 2019-11-29
NO2019021I1 (no) 2019-04-30
DK3085381T3 (en) 2018-05-28
NO2296686T3 (hu) 2014-07-12
TR201807224T4 (tr) 2018-06-21
LT3225249T (lt) 2019-01-10
JP2011520980A (ja) 2011-07-21
SI3225249T1 (sl) 2019-02-28
JP2019123739A (ja) 2019-07-25
PT3225250T (pt) 2019-10-15
HRP20180774T1 (hr) 2018-08-10
SI3085381T1 (en) 2018-06-29
ES2596435T3 (es) 2017-01-09
US20180250357A1 (en) 2018-09-06
HUE039013T4 (hu) 2019-08-28
PL3225249T3 (pl) 2019-05-31

Similar Documents

Publication Publication Date Title
HUS1900024I1 (hu) Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
GB2468870B (en) Sensor
GB0912009D0 (en) Sensor
EP2443235A4 (en) ß-glucosidase VARIANTS
ZA201108691B (en) Electrochemical sensor
EP2438246A4 (en) CONSTRUCTION ASPECTS
EP2439542A4 (en) SENSOR FOR PHYSICAL SIZE
EP2433104A4 (en) SENSOR
TWM372016U (en) Improved structure of USB
GB0903383D0 (en) Sensor
EP2407765A4 (en) PHYSICAL QUANTITIES DETECTOR
EP2496934A4 (en) MOISTURE MEASUREMENT
GB0915492D0 (en) Sensor
GB0920788D0 (en) Ski
GB0917735D0 (en) Sensor
GB0908794D0 (en) Sensor
TWM372743U (en) Improved structure of Kendama
TWM365675U (en) Improved structure of teapoy
GB0915162D0 (en) Electrochemical sensor
PL118379U1 (pl) Słupek pomiarowy
TWM387152U (en) Oxygen sensor
GB0913435D0 (en) Sensor
GB0916620D0 (en) Sensor
GB0900683D0 (en) Sensor
GB0911104D0 (en) Hikeing stick